Clinical Trial Update: Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating bosentan for mild pulmonary vascular disease in patients with atrial septal defect has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Heart Septal Defects, Atrial | Phase 3 | Status: COMPLETED